+28.2%
MRNA vs EXPD
+69.2%
-41.0%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EXPD | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +1.3% | -4.6% | -4.0% |
| 7D | -10.1% | +1.2% | -11.2% | -10.6% |
| 30D | +126.7% | +5.2% | +121.5% | +121.4% |
| 3M | +184.1% | +13.2% | +170.9% | +166.7% |
| 6M | +143.3% | +30.3% | +113.0% | +111.2% |
| YTD | +359.9% | +27.0% | +332.8% | +297.8% |
| 1Y | +454.2% | +57.3% | +396.9% | +314.6% |
| All | +28.2% | +69.2% | -41.0% | -8.8% |
Cumulative growth
Daily Returns
Daily percentage return beside EXPD.
Daily Out/Under-Performance
Portfolio return minus EXPD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EXPD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EXPD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling